Actinium Pharmaceuticals, Inc.
Actinium Pharmaceuticals, Inc. (ATNM) — Form DEF 14A: Proxy statement
About this filing
Actinium Pharmaceuticals, Inc. (ATNM) filed Form DEF 14A (proxy statement) with the SEC on Oct 16, 2026.
Key facts
- Document
- PROXY STATEMENT
More ATNM filings
- 4
Filed Oct 16, 2026
- 3
Filed Oct 16, 2026
- ARS
Filed Oct 16, 2026
- 8-K
Filed Oct 15, 2026
- S-8
Filed Oct 9, 2026
- 3
Filed Sep 10, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.